Fox Chase Cancer Center News

Fox Chase Cancer Center Researchers Uncover ONC201 Immune-oncology Effects

PHILADELPHIA ( [Anchor] March 20, 2018) – The Journal of Clinical Investigation recently published a scientific article describing ONC201’s ability to cause intratumoral accumulation and activation of natural killer (NK) and CD3+ T cells in mouse models and patients. The research is from the laboratory of Wafik El-Deiry MD, PhD, FACP, Scientific Founder of Oncoceutics, and Deputy Cancer Center Director for Translational Research at Fox Chase Cancer Center.

VIEW STORY

Fox Chase Cancer Center Urges Patients to Get a Colorectal Cancer Screening

PHILADELPHIA (March 1, 2018) – March is National Colorectal Cancer Awareness Month, and Fox Chase Cancer Center encourages individuals to get a colorectal cancer screening. “Regular screening continues to be the best defense against colorectal cancer. It can detect pre-cancerous growths as well as cancer, which is highly treatable if caught early,” said David Weinberg, MD, chair of medicine and chief of the gastroenterology section at Fox Chase Cancer Center.

VIEW STORY